ALX Oncology annual meeting results: all three director nominees elected, proposals approved

ALX ONCOLOGY HOLDINGS INC

Corey Goodman, Jason Lettmann, Sophia Randolph elected as Class I directors for terms until 2027.
Advisory vote on executive compensation approved: 40,935,354 for, 1,422,239 against, 34,391 abstain.
Ratification of KPMG as independent auditor for FY 2024 approved: 47,698,670 for, 11,338 against, 2,733 abstain.
Broker non-votes: 5,320,757 on director elections and advisory compensation vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.